ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 51 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $25,000 | -35.9% | 145,381 | 0.0% | 0.00% | – |
Q2 2022 | $39,000 | -52.4% | 145,381 | -0.6% | 0.00% | – |
Q1 2022 | $82,000 | -20.4% | 146,291 | 0.0% | 0.00% | – |
Q4 2021 | $103,000 | -16.9% | 146,291 | +92.2% | 0.00% | – |
Q3 2021 | $124,000 | +416.7% | 76,122 | +537.6% | 0.00% | – |
Q2 2021 | $24,000 | -89.9% | 11,939 | -83.3% | 0.00% | – |
Q1 2021 | $237,000 | -16.8% | 71,282 | -0.4% | 0.00% | – |
Q4 2020 | $285,000 | +44.7% | 71,568 | -4.5% | 0.00% | – |
Q3 2020 | $197,000 | +0.5% | 74,979 | +15.6% | 0.00% | – |
Q2 2020 | $196,000 | +46.3% | 64,842 | -5.5% | 0.00% | – |
Q1 2020 | $134,000 | -73.5% | 68,651 | 0.0% | 0.00% | – |
Q4 2019 | $505,000 | +74.1% | 68,651 | +7.0% | 0.00% | – |
Q3 2019 | $290,000 | -53.5% | 64,185 | +2.6% | 0.00% | – |
Q2 2019 | $624,000 | -23.7% | 62,572 | -10.6% | 0.00% | – |
Q1 2019 | $818,000 | +1.5% | 70,008 | +4.3% | 0.00% | – |
Q4 2018 | $806,000 | -25.3% | 67,111 | +6.0% | 0.00% | – |
Q3 2018 | $1,079,000 | +3.9% | 63,311 | +4.1% | 0.00% | – |
Q2 2018 | $1,038,000 | – | 60,815 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 375,000 | $3,739,000 | 1.40% |
CVI Holdings, LLC | 223,140 | $2,226,000 | 0.86% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,202,456 | $21,958,000 | 0.59% |
Ion Asset Management Ltd. | 225,000 | $2,243,000 | 0.57% |
Altshuler Shaham Ltd | 1,093,859 | $11,343,000 | 0.48% |
MEITAV INVESTMENT HOUSE LTD | 500,436 | $4,987,000 | 0.33% |
Clal Insurance Enterprises Holdings Ltd | 595,000 | $5,932,000 | 0.14% |
New England Private Wealth Advisors LLC | 50,000 | $499,000 | 0.12% |
EMERALD MUTUAL FUND ADVISERS TRUST | 200,000 | $1,994,000 | 0.08% |
ING GROEP NV | 30,000 | $299,000 | 0.01% |